Similar articles

• Olanzapine versus divalproex in the treatment of acute mania.

  Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, Milton DR, Risser R, Gilmore JA, Breier A, Tollefson GA. Tohen M, et al. Am J Psychiatry. 2002 Jun;159(6):1011-7. doi: 10.1176/appi.ajp.159.6.1011. Am J Psychiatry. 2002. PMID: 12042191 Clinical Trial.
• Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.

  Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW. Tohen M, et al. Am J Psychiatry. 2003 Jul;160(7):1263-71. doi: 10.1176/appi.ajp.160.7.1263. Am J Psychiatry. 2003. PMID: 12832240 Clinical Trial.
• Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.

  Suppes T, Brown E, Schuh LM, Baker RW, Tohen M. Suppes T, et al. J Affect Disord. 2005 Dec;89(1-3):69-77. doi: 10.1016/j.jad.2005.07.011. Epub 2005 Oct 25. J Affect Disord. 2005. PMID: 16253344
• Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.

  Goodwin FK. Goodwin FK. J Clin Psychiatry. 2003;64 Suppl 5:18-24. J Clin Psychiatry. 2003. PMID: 12720480 Review.
• Treatment of bipolar mania with atypical antipsychotics.

  Chengappa KN, Suppes T, Berk M. Chengappa KN, et al. Expert Rev Neurother. 2004 Nov;4(6 Suppl 2):S17-25. doi: 10.1586/14737175.4.6.S17. Expert Rev Neurother. 2004. PMID: 16279862 Review.